Views & Analysis | Perspectives on pharma industry issues

R&D

LSX2026: Non-opioid pain relief and pharma positivity, with ...

Mike Cooke, CEO of AmacaThera, spoke with pharmaphorum at the LSX World Congress, including about non-opioid pain relief.

Sales & Marketing

The UK’s medicine supply is about to be tested and pharmacie...

The current disruption shows supply chains are not abstract systems, but physical networks, dependent on specific routes, materials & decisions.

Digital

Trends outside the headlines, people reviewing graphs

Trends & Insights: February 2026 – A pharmaphorum industry r...

February's Trends Outside the Headlines, trends & insights report showed competitive advantage is increasingly shaped by delivery, not just discovery.

R&D

Scientist using manual and AI methods in lab

From in silico to in vivo: Why development strategy now dete...

As discovery becomes faster and more accessible, the differentiator shifts downstream.

R&D

handshake and corporate body in the background of

Changing Faces: Pharma and biotech, March 2026

A broad mix of senior leadership and scientific and commercial appointments shaped last month’s pharma and biotech hiring activity.

Digital

Digital tools must be used in pharma manufacturing to keep p...

The pace of change in drug discovery and clinical development has been unmatched in recent years, with technologies such as AI accelerating these processes.

R&D

Automation of literature search and review

Over the years, pharmacovigilance (PV) processes have relied on PV professionals manually sifting through large volumes of data to identify, assess, and report Adverse Event (AE) informatio

Oncology

12 Questions with Jorge Reis-Filho

As Vice President of Cancer Biomarker Development at AstraZeneca, Jorge Reis-Filho seeks to develop and validate the next generation of mechanistically informed and clinically deployable bi

Sales & Marketing

The UK’s medicine supply is about to be tested and pharmacie...

The current disruption shows supply chains are not abstract systems, but physical networks, dependent on specific routes, materials & decisions.

Sales & Marketing

How war in the Middle East is disrupting medical supply chai...

The impact of the geopolitical disruption is starting to tell on global supply chains for medicines and key chemicals for the pharmaceutical industry.

Digital

Trends & Insights: February 2026 – A pharmaphorum industry r...

February's Trends Outside the Headlines, trends & insights report showed competitive advantage is increasingly shaped by delivery, not just discovery.

Digital

Augmented intelligence: The next-gen engine for biopharma in...

Augmented intelligence is strategically valuable because it strengthens both the scientific and financial case for every decision.

Market Access

General Counsel in corporate environment

For life sciences, it’s not only about when to bring on a GC...

For founders, the question is no longer just who to hire as GC, but when to hire them, and what comes next.

Market Access

Young girl gives high five to her female doctor, mum also in the consult room

A step forward, but not the finish line: What NICE’s QALY up...

Healthcare in the UK is at an inflection point.

Oncology

LSX2026: Addressing adult eye cancer, with Roi Raz

Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.

Oncology

From preclinical toxicology to clinical safety: The path for...

Successfully navigating the process for drugs with a higher risk-benefit ratio requires a tailored non-clinical programme design.

Oncology

Advancing the case for cell and gene therapies

After the Advanced Therapies Congress, Europe, pharmaphorum spoke with Resolution Therapeutics' Lara Campana and Vianautis' Dr Sam Barker.

Patients

Female patient engages with her female doctor

Return on Engagement (ROE): A new framework to better captur...

Return on Engagement (ROE) is a call to action to better capture the multifaceted value of patient engagement.

Patients

Brain puzzle with piece missing, letting through the sunlight

Exploring mixed episodes in bipolar I disorder: When mania a...

One of the most misunderstood and often overlooked aspects of BD-I is the occurrence of mixed episodes.

Patients

Interview with Matt Wadyka at Reuters Pharma USA 2026

Making direct-to-patient work, with Matt Wadyka

Matt Wadyka, chief client strategy officer at Inizio Medical, spoke to pharmaphorum about the ins and outs of direct-to-patient programmes in pharma.

Sales & Marketing

Digital

Market Access

Editor's Picks

Oncology

Patients

R&D

Editor's Picks